Protein/NN
kinase/NN
B/NN
(/(
c-Akt/NN
)/)
,/,
phosphatidylinositol/NN
3-kinase/NN
,/,
and/CC
STAT5/NN
are/VBP
activated/VBN
by/IN
erythropoietin/NN
(/(
EPO/NN
)/)
in/IN
HCD57/NN
erythroid/JJ
cells/NNS
but/CC
are/VBP
constitutively/RB
active/JJ
in/IN
an/DT
EPO-independent/JJ
,/,
apoptosis-resistant/JJ
subclone/NN
(/(
HCD57-SREI/NN
cells/NNS
)/)
./.

We/PRP
found/VBD
that/IN
erythropoietin/NN
(/(
EPO/NN
)/)
and/CC
stem/VBP
cell/NN
factor/NN
(/(
SCF/NN
)/)
activated/VBD
protein/NN
kinase/NN
B/NN
(/(
PKB/Akt/NN
)/)
in/IN
EPO-dependent/JJ
HCD57/NN
erythroid/JJ
cells/NNS
./.
=====
To/TO
better/RBR
understand/VB
signals/NNS
controlling/VBG
proliferation/NN
and/CC
viability/NN
,/,
erythroid/JJ
cells/NNS
that/WDT
resist/VBP
apoptosis/NN
in/IN
the/DT
absence/NN
of/IN
EPO/NN
were/VBD
subcloned/VBN
and/CC
characterized/VBN
(/(
HCD57-SREI/NN
cells/NNS
)/)
./.
=====
Constitutive/JJ
activations/NNS
of/IN
PKB/Akt/NN
,/,
STAT5a/NN
,/,
and/CC
STAT5b/NN
were/VBD
noted/VBN
in/IN
these/DT
EPO-independent/JJ
cells/NNS
./.
=====
PI3-kinase/NN
activity/NN
was/VBD
an/DT
upstream/JJ
activator/NN
of/IN
PKB/Akt/NN
because/IN
the/DT
PI3-kinase/NN
inhibitor/NN
LY294002/NN
blocked/VBD
both/CC
constitutive/JJ
PKB/Akt/NN
and/CC
factor-dependent/JJ
PKB/Akt/NN
activity/NN
./.
=====
The/DT
LY294002/NN
study/NN
showed/VBD
that/IN
proliferation/NN
and/CC
viability/NN
of/IN
both/CC
HCD57-SREI/NN
and/CC
HCD57/NN
cells/NNS
correlated/VBD
with/IN
the/DT
activity/NN
of/IN
PKB/Akt/NN
;/:
however/RB
,/,
PKB/Akt/NN
activity/NN
alone/RB
did/VBD
not/RB
protect/VB
these/DT
cells/NNS
from/IN
apoptosis/NN
./.
=====
Treatment/NN
of/IN
HCD57/NN
cells/NNS
with/IN
SCF/NN
also/RB
activated/VBD
PKB/Akt/NN
,/,
but/CC
did/VBD
not/RB
protect/VB
from/IN
apoptosis/NN
./.
=====
This/DT
result/NN
suggested/VBD
that/IN
PKB/PI3-kinase/NN
activity/NN
is/VBZ
necessary/JJ
but/CC
not/RB
sufficient/JJ
to/TO
promote/VB
viability/NN
and/or/CC
proliferation/NN
./.
=====
Constitutive/JJ
STAT5/NN
activity/NN
,/,
activated/VBN
through/IN
an/DT
unknown/JJ
pathway/NN
not/RB
including/VBG
JAK2/NN
or/CC
EPOR/NN
,/,
may/MD
act/VB
in/IN
concert/NN
with/IN
the/DT
constitutive/JJ
PI3-kinase/PKB/Akt/NN
pathway/NN
to/TO
protect/VB
the/DT
EPO-independent/JJ
HCD57-SREI/NN
cells/NNS
from/IN
apoptosis/NN
and/CC
promote/VB
limited/JJ
proliferation/NN
./.